Newmont (NEM) Raised to Strong Buy: Key Information You Need
Newmont Corporation Earns Top Zacks Rating
Newmont Corporation (NEM) has recently been elevated to a Zacks Rank #1 (Strong Buy), signaling its potential as a valuable addition to your investment portfolio. This upgrade reflects improving earnings forecasts, a key driver behind stock price changes.
Understanding the Zacks Rating System
The Zacks rating is determined solely by shifts in a company's earnings outlook. The system monitors the Zacks Consensus Estimate, which aggregates EPS projections from analysts covering the stock for both the current and upcoming years.
Because earnings estimate revisions are closely linked to short-term stock price movements, the Zacks rating system offers individual investors a practical tool for making decisions. Unlike Wall Street analyst upgrades, which often rely on subjective factors, Zacks focuses on measurable changes in earnings expectations.
Newmont's recent Zacks rating upgrade highlights its positive earnings trajectory, suggesting a potential boost in its share price.
Key Factors Influencing Stock Prices
Adjustments in a company's projected earnings, as seen in estimate revisions, have a strong connection to short-term stock price shifts. Institutional investors frequently use these estimates to determine a stock's fair value, and changes in their models can prompt significant buying or selling activity, which in turn moves the stock price.
For Newmont, rising earnings estimates and its upgraded rating indicate an improvement in the company's core business. Investors often respond to such positive trends by driving the stock higher.
Leveraging Earnings Estimate Revisions
Research consistently shows that tracking earnings estimate revisions can be a highly effective strategy for investors. The Zacks Rank stock-rating system capitalizes on this relationship, helping investors identify stocks poised for near-term gains.
Using four earnings-related factors, Zacks sorts stocks into five categories, from Strong Buy (#1) to Strong Sell (#5). Zacks Rank #1 stocks have historically delivered an average annual return of 25% since 1988.
Newmont's Earnings Outlook
Newmont, a leading gold and copper producer, is projected to earn $8.15 per share for the fiscal year ending December 2026, with no change compared to the previous year.
Over the past quarter, analysts have raised their earnings estimates for Newmont by 13.8%, reflecting growing confidence in the company's performance.
Summary
Unlike Wall Street rating systems, which often lean toward positive recommendations, Zacks maintains a balanced approach, assigning equal numbers of "buy" and "sell" ratings across more than 4,000 stocks. Only the top 5% receive a "Strong Buy" rating, and the next 15% are labeled as "Buy." Being ranked in the top 20% signals robust earnings estimate revisions, making Newmont a strong candidate for outperforming the market in the near future.
With its upgrade to Zacks Rank #1, Newmont now sits among the top 5% of Zacks-covered stocks for estimate revisions, suggesting the stock may see further gains soon.
Zacks Research Chief Reveals Top Stock Picks
Zacks experts have identified five stocks with the highest likelihood of doubling in value in the coming months. Among these, Director of Research Sheraz Mian spotlights a standout satellite communications company, which is positioned to benefit from the rapidly expanding space industry. Analysts expect a significant revenue surge in 2025. While not all picks achieve their targets, this selection could outperform previous Zacks winners, such as Hims & Hers Health, which soared over 200%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
$805B Wiped Out in Sudden US Stock Market Crash
Erste Group Downgrades Walmart (WMT) to Hold from Buy; FTC Settlement Adds Pressure

Costco Says Tariff Refunds Could Lead to Lower Prices for Customers

BofA Boosts Johnson & Johnson (JNJ) Price Target as Pipeline Outlook Improves

